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ABSTRACT 
 
 
Breast cancer in South Africa has become one of the most prominent cancers affecting 
women. Worldwide, breast cancer results in more deaths amongst women than any other 
cancer (Vorobiof, 2001). Chemotherapy has become one of the most effective and 
commonly used adjuvant forms of treatment in breast cancer. However, despite its 
effectiveness, it has a variety of side effects ranging from nausea, fatigue, vomiting, 
alopecia to many others. Due to the significant levels of discomfort and disability 
associated with chemotherapy, patients often seek additional treatment to assist with 
these side effects. Many individuals combine complementary and alternative therapies 
with conventional treatment of their cancer (Breasthealth, 2005). Homoeopathy is often 
used to alleviate the side-effects resulting from the chemotherapy treatments (Diamond 
and Crowden, 1997).  
 
This research involved the individualized treatment of patients experiencing side effects 
from chemotherapy, employing homeopathic medicine. The study involved ten 
participants who had been diagnosed with breast cancer and who were scheduled for at 
least four chemotherapy treatments. The participants did not receive any homoeopathic 
remedies to assist with the side effects following the first chemotherapy treatment. The 
results from the first chemotherapy treatment were utilized to establish each individual’s 
control results against which, future results would be compared. Participants received 
their homoeopathic similimum remedies to assist with their second, third and fourth 
chemotherapies. The appropriate homoeopathic remedy was determined using each 
patient’s distinguishing, mental, emotional and physical symptoms following each 
chemotherapy treatment.  
 
Each participant completed the Researcher’s Questionnaires (Appendix B) following 
their chemotherapy treatments and recorded the severity of their nausea, fatigue, 
vomiting and general symptoms experienced after each of the four chemotherapies. These 
were handed to the researcher at each follow-up consultation. These results, together with 
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the holistic progress as noted by the researcher at every consultation, were used to 
determine the efficacy of homoeopathy on the side effects of chemotherapy treatment.  
 
This study aimed to reduce the severity and duration of side effects resulting from 
chemotherapy treatment using individual homoeopathic remedies prescribed. The 
severity of side effects was graded and monitored for each patient following each  
chemotherapy session.  
 
Of the ten participants involved in this study, eight participants completed all their 
scheduled chemotherapy sessions. Two of the participants completed only three 
chemotherapies as their conditions had improved drastically and were not compelled to 
complete their remaining chemotherapies. Compliance with the homoeopathic treatments 
was thus effectively 100%. 
 
The results of this study indicated that all of the participants reported a statistically 
significant decrease in side effects after taking the similimum homoeopathic remedies 
and they also experienced a shorter duration of side effects. All patients in this study were 
better able to cope with the side effects of chemotherapy whilst taking the similimum 
Homoeopathic remedies.  
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